Successful treatment of lung cancer coexisting with B-cell lymphoma with pembrolizumab following rituximab-included chemotherapy: A case report

In conclusion, the present study suggested that pembrolizumab, following rituximab-containing therapy, could be a treatment option for patients with lung cancer coexisting with MALT lymphoma.PMID:38476337 | PMC:PMC10928651 | DOI:10.3892/mco.2024.2731

Source: Clinical Lung Cancer - March 13, 2024 Category: Cancer & Oncology Authors: Daisuke Natori Hiroaki Ozasa Yusuke Shima Chisaki Mizumoto Keiichiro Suminaga Takashi Nomizo Hitomi Ajimizu Hironori Yoshida Toyohiro Hirai Source Type: research